GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (OTCPK:CGNSF) » Definitions » Equity-to-Asset

CGNSF (Cognetivity Neurosciences) Equity-to-Asset : -31.22 (As of Oct. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cognetivity Neurosciences's Total Stockholders Equity for the quarter that ended in Oct. 2023 was $-11.08 Mil. Cognetivity Neurosciences's Total Assets for the quarter that ended in Oct. 2023 was $0.36 Mil. Therefore, Cognetivity Neurosciences's Equity to Asset Ratio for the quarter that ended in Oct. 2023 was -31.22.

The historical rank and industry rank for Cognetivity Neurosciences's Equity-to-Asset or its related term are showing as below:

CGNSF's Equity-to-Asset is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.49
* Ranked among companies with meaningful Equity-to-Asset only.

Cognetivity Neurosciences Equity-to-Asset Historical Data

The historical data trend for Cognetivity Neurosciences's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Equity-to-Asset Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Equity-to-Asset
Get a 7-Day Free Trial 0.67 -0.35 0.47 -2.83 -3.50

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.34 -3.50 -8.76 -24.25 -31.22

Competitive Comparison of Cognetivity Neurosciences's Equity-to-Asset

For the Health Information Services subindustry, Cognetivity Neurosciences's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cognetivity Neurosciences's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's Equity-to-Asset falls into.



Cognetivity Neurosciences Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cognetivity Neurosciences's Equity to Asset Ratio for the fiscal year that ended in Jan. 2023 is calculated as

Equity to Asset (A: Jan. 2023 )=Total Stockholders Equity/Total Assets
=-7.368/2.108
=-3.50

Cognetivity Neurosciences's Equity to Asset Ratio for the quarter that ended in Oct. 2023 is calculated as

Equity to Asset (Q: Oct. 2023 )=Total Stockholders Equity/Total Assets
=-11.082/0.355
=-31.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cognetivity Neurosciences  (OTCPK:CGNSF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Cognetivity Neurosciences Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences Business Description

Traded in Other Exchanges
N/A
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences Headlines

From GuruFocus

The Most Innovative Healthcare AI Developments of 2019

By ACCESSWIRE AccessWire 04-12-2019